Newhouse op-ed on clinical trials, Alzheimer's featured in Tennessean

March 7, 2019

Paul Newhouse, M.D., Jim Turner Chair in Cognitive Disorders, professor of Psychiatry & Behavioral Sciences, Pharmacology, and Medicine, and director of the Vanderbilt Center for Cognitive Medicine, recently contributed an opinion piece to the Tennessean titled "A cure for Alzheimer’s is not possible without you." Click here to view the opinion piece.

Newhouse study explores nicotine patch to treat memory loss

November 4, 2015

VUMC has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease. Paul Newhouse, M.D., professor of Psychiatry and director of the Center for Cognitive Medicine at VUMC, is the co-principal investigator of the study that is being launched in conjunction with the Alzheimer’s Treatment Research Institute at the University of Southern California, Indiana University and the University of Vermont.